Reini Juhani Hurme
Director Ejecutivo en Zora Biosciences Oy .
Cargos activos de Reini Juhani Hurme
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Zora Biosciences Oy
 Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Director Ejecutivo | 14/12/2006 | - |
| Fundador | 14/12/2006 | - |
Historial de carrera de Reini Juhani Hurme
Antiguos cargos conocidos de Reini Juhani Hurme.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Schering Oy | Corporate Officer/Principal | - | - |
Leiras Oy
 Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Finlandia | 4 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorial
| Health Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Zora Biosciences Oy
Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Health Services |
Leiras Oy
Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Health Technology |
| Schering Oy |
- Bolsa de valores
- Insiders
- Reini Juhani Hurme
- Experiencia
